Mycosis fungoides

Refining Prognostication in Advanced Mycosis Fungoides and Sézary Syndrome: The Role of the Cutaneous Lymphoma International Prognostic Index (CLIPI)

By MedXY 10/14/2026

The Cutaneous Lymphoma International Prognostic Index (CLIPI) enhances risk stratification and predicts progression and treatment response beyond conventional staging in advanced mycosis fungoides and Sézary syndrome.

Dermatology Hematology-Oncology news

JAK2 Gene Fusions in Adult Patients with Mycosis Fungoides and CD30-Positive Lymphoproliferative Disorders: A Case Series

By MedXY 11/27/2025

This case series highlights the presence and clinical significance of JAK2 gene fusions across a spectrum of cutaneous T-cell lymphomas, including indolent and aggressive presentations.

Dermatology Hematology-Oncology news

Large-Cell Transformation of Mycosis Fungoides: Clinical Patterns, Prognostic Insights, and Implications for Staging

By MedXY 10/14/2025

Large-cell transformation in mycosis fungoides marks an aggressive disease subset with distinct prognostic groups and poor survival, highlighting the need for tailored treatment and integration into staging systems.

Dermatology Hematology-Oncology news

CLIPI: A New Prognostic Index Transforming Risk Stratification in Advanced Cutaneous Lymphomas

By MedXY 10/14/2025

The CLIPI prognostic index refines risk stratification in advanced mycosis fungoides and Sézary syndrome, identifying distinct survival groups to guide personalized treatment decisions and improve outcomes.